Zhejiang Garden Bio-chemical High-tech Co Ltd Market Cap ($986.13 Million)
Market Cap & Net Worth: Zhejiang Garden Bio-chemical High-tech Co Ltd (300401)
Zhejiang Garden Bio-chemical High-tech Co Ltd market cap. Zhejiang Garden Bio-chemical High-tech Co Ltd (SHE:300401) has a market capitalization of $986.13 Million (CN¥6.74 Billion) as of November 5, 2026. Listed on the SHE stock exchange, this China-based company holds position #8680 globally and #2011 in its home market, demonstrating a 2.82% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zhejiang Garden Bio-chemical High-tech Co Ltd's stock price CN¥12.40 by its total outstanding shares 543469905 (543.47 Million). Also see cash efficiency ratio of Zhejiang Garden Bio-chemical High-tech C for how efficiently the company converts equity into cash flow.
Zhejiang Garden Bio-chemical High-tech Co Ltd Market Cap History (2015–2026)
Zhejiang Garden Bio-chemical High-tech Co Ltd market cap history from 2015 to 2026. Data shows growth from $862.03 Million to $986.13 Million (4.78% CAGR). Check 300401 live share price for real-time trading data and today's change.
Zhejiang Garden Bio-chemical High-tech Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zhejiang Garden Bio-chemical High-tech Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 300401 shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.94x
Zhejiang Garden Bio-chemical High-tech Co Ltd's market cap is 0.94 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.77x
Zhejiang Garden Bio-chemical High-tech Co Ltd's market cap is 3.77 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $862.03 Million | $151.22 Million | $12.07 Million | 5.70x | 71.39x |
| 2016 | $1.15 Billion | $329.09 Million | $43.77 Million | 3.49x | 26.20x |
| 2017 | $1.33 Billion | $419.87 Million | $130.40 Million | 3.17x | 10.21x |
| 2018 | $919.31 Million | $660.22 Million | $307.41 Million | 1.39x | 2.99x |
| 2019 | $952.11 Million | $718.38 Million | $343.71 Million | 1.33x | 2.77x |
| 2020 | $1.22 Billion | $659.44 Million | $263.22 Million | 1.84x | 4.62x |
| 2021 | $1.11 Billion | $1.12 Billion | $483.77 Million | 0.99x | 2.29x |
| 2022 | $1.12 Billion | $1.42 Billion | $383.72 Million | 0.79x | 2.93x |
| 2023 | $933.82 Million | $1.09 Billion | $192.35 Million | 0.85x | 4.85x |
| 2024 | $1.17 Billion | $1.24 Billion | $309.21 Million | 0.94x | 3.77x |
Competitor Companies of 300401 by Market Capitalization
Companies near Zhejiang Garden Bio-chemical High-tech Co Ltd in the global market cap rankings as of November 5, 2026. Also see Zhejiang Garden Bio-chemical High-tech C asset portfolio for a full breakdown of the balance sheet.
Key companies related to Zhejiang Garden Bio-chemical High-tech Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #514 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #538 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #588 globally with a market cap of $45.79 Billion USD ( CN¥312.89 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #621 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #514 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #538 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $47.80 |
| #588 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.79 Billion | CN¥49.05 |
| #621 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Zhejiang Garden Bio-chemical High-tech Co Ltd (2015–2026)
Market capitalization of Zhejiang Garden Bio-chemical High-tech Co Ltd from 2015 to today. Between 2015 and today, Zhejiang Garden Bio-chemical High-tech Co Ltd's market cap moved from $862.03 Million to $ 986.13 Million, with a yearly change of 4.78%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥986.13 Million | -17.99% |
| 2025 | CN¥1.20 Billion | +3.14% |
| 2024 | CN¥1.17 Billion | +24.85% |
| 2023 | CN¥933.82 Million | -16.99% |
| 2022 | CN¥1.12 Billion | +1.52% |
| 2021 | CN¥1.11 Billion | -8.87% |
| 2020 | CN¥1.22 Billion | +27.71% |
| 2019 | CN¥952.11 Million | +3.57% |
| 2018 | CN¥919.31 Million | -30.94% |
| 2017 | CN¥1.33 Billion | +16.07% |
| 2016 | CN¥1.15 Billion | +33.05% |
| 2015 | CN¥862.03 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Zhejiang Garden Bio-chemical High-tech Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $986.13 Million USD |
| MoneyControl | $986.13 Million USD |
| MarketWatch | $986.13 Million USD |
| marketcap.company | $986.13 Million USD |
| Reuters | $986.13 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Zhejiang Garden Bio-chemical High-tech Co Ltd
Zhejiang Garden Biopharmaceutical Co.,Ltd. operates as a food additive and pharmaceutical manufacturing industry in China. The company provides lanolin cholesterol, vitamin A and AD3 particles, vitamin D3, 25-hydroxyvitamin D3, chemical drugs and Chinese patent medicines. It offers cholesterol; feed grade vitamin D3, refined lanolin; food additives compound nutrient fortifier SDS, CO, and MO; cho… Read more